Ventolin hfa and Epivir drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Ventolin hfa (albuterol sulfate) and Epivir (lamivudine). Common drug interactions include malaise among females and anhedonia among males.

The phase IV clinical study analyzes what interactions people have when they take Ventolin hfa and Epivir. It is created by eHealthMe based on reports of 43 people who take the same drugs from the FDA, and is updated regularly.

What is Ventolin hfa?

Ventolin hfa has active ingredients of albuterol sulfate. It is often used in asthma. eHealthMe is studying from 40,061 Ventolin hfa users. Check the latest studies of Ventolin hfa.

What is Epivir?

Epivir has active ingredients of lamivudine. It is often used in hiv infection. eHealthMe is studying from 16,870 Epivir users. Check the latest studies of Epivir.



On Jul, 12, 2026

43 people who take Ventolin hfa and Epivir together, and have interactions are studied.

Ventolin hfa and Epivir drug interactions.

What are the common drug interactions of Ventolin Hfa and Epivir, by gender? *:

female:

  1. Malaise (a feeling of general discomfort or uneasiness)
  2. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  3. Nausea (feeling of having an urge to vomit)
  4. Urinary tract infection
  5. Anxiety
  6. Emotional distress
  7. Pain
  8. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  9. Depression
  10. Renal failure (kidney dysfunction)

male:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Anxiety
  3. Bone density decreased
  4. Mobility decreased (ability to move is reduced)
  5. Decreased activity
  6. Hypertension (high blood pressure)
  7. Anaemia (lack of blood)
  8. Foot fracture
  9. Hyperkalaemia (damage to or disease of the kidney)
  10. Spinal fracture (fracture in one of vertebrae)

What are the common drug interactions of Ventolin Hfa and Epivir, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Anxiety
  3. Chronic kidney disease
  4. Decreased activity
  5. Emotional distress
  6. Fatigue (feeling of tiredness)
  7. Pain
  8. Quality of life decreased
  9. Gait disturbance
  10. Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)

30-39:

n/a

40-49:

  1. Tibia fracture (fracture of lower leg bone)
  2. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  3. Anxiety
  4. Emotional distress
  5. Pain
  6. Renal failure (kidney dysfunction)
  7. Chronic kidney disease
  8. Depression
  9. Osteoporosis (bones weak and more likely to break)
  10. Anaemia (lack of blood)

50-59:

  1. Anxiety
  2. Emotional distress
  3. Renal failure (kidney dysfunction)
  4. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  5. Depression
  6. Pain
  7. Osteonecrosis (death of bone)
  8. Bone density decreased
  9. Bone loss
  10. Fatigue (feeling of tiredness)

60+:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Anxiety
  3. Ankle fracture
  4. Gait disturbance
  5. Hepatic cirrhosis (chronic liver disease characterized by replacement of liver tissue by fibrosis, scar tissue)
  6. Hypertension (high blood pressure)
  7. Immunosuppression
  8. Influenza
  9. Renal impairment (severely reduced kidney function)
  10. Viral infection

What are the existing conditions these people have? *

  1. Hiv Infection: 37 people, 86.05%
  2. Hyperlipidaemia (presence of excess lipids in the blood): 7 people, 16.28%
  3. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 7 people, 16.28%
  4. Pain: 6 people, 13.95%
  5. High Blood Pressure: 6 people, 13.95%
  6. High Blood Cholesterol: 6 people, 13.95%
  7. Bacterial Infection: 6 people, 13.95%
  8. Multiple Myeloma (cancer of the plasma cells): 5 people, 11.63%
  9. Depression: 5 people, 11.63%
  10. Osteoporosis (bones weak and more likely to break): 4 people, 9.30%

* Approximation only. Some reports may have incomplete information.

Do you take Ventolin hfa and Epivir?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Ventolin hfa and Epivir:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Ventolin hfa:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Epivir:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ventolin hfa and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Epivir and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on albuterol sulfate and lamivudine (the active ingredients of Ventolin hfa and Epivir, respectively), and Ventolin hfa and Epivir (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: